Brand-name vs compounded
Ro.co vs TMates: Brand-Name or Compounded? (2026)
Ro.co or TMates? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Ro.co and TMates usually comes down to one difference that neither homepage puts in its headline.
Choosing between them is really choosing between an approved finished drug and a compounded preparation. Ro.co sits on one side of that line and TMates on the other, and no amount of feature comparison makes the distinction go away.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $199/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Quickest to start
- Ro.co — Online consultation, then home delivery.
- Easiest to pay for
- Ro.co — Neither publishes financing; both expect the full amount monthly.
Side-by-side comparison
The rows below are the ones that differ enough between these two to be worth your attention.
| Ro.co | TMates | |
|---|---|---|
| Advertised price | Get started online for $39 | $199/mo at every dose, no step-up fees |
| Rate after promotions | $39/mo | $199/mo |
| Pricing structure | Promotional first month, then standard rate | Flat rate at every dose |
| Medication | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables | Compounded semaglutide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Online consultation | Virtual check-in appointments |
| State coverage | Not published | All 50 states |
| Patient reviews | 40,215 | 21,970 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
Ro.co vs TMates on total cost, not entry price
Comparing entry prices across these two would be actively misleading, because they escalate differently. Here is what each one costs across a realistic course of treatment, on published pricing.
| Ro.co | TMates | |
|---|---|---|
| First month | $39 | $199 |
| Months 2 onward | Not published | $199/mo |
| 6-month total | Not computable | $1,194 |
| 12-month total | Not computable | $2,388 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
The regulatory difference, in plain terms
Ro.co supplies FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
Across from that, TMates offers compounded semaglutide — prepared by a pharmacy rather than manufactured under approval. The price advantage and the reduced oversight are the same fact seen from two sides.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, TMates exists for a reason.
Ro.co in detail
The pitch is the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
You start with online consultation; medication arrives via home delivery. The price behaves as promotional first month, then standard rate.
On the clinical side, established full-service platform with clinician oversight, prescribing FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- No hidden fees; pricing disclosed before you complete your consultation
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Get started online for just $39
- FDA-approved finished medication, not compounded
Ro.co cons
- Less price-competitive than compounded-only platforms for budget-driven patients
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
Where it gives ground to TMates: an FDA-approved finished medication costs multiples of a compounded vial.
TMates: what you are buying
$199/month, every dose, no step-up fees
The process is virtual check-in appointments, then medication formulated in U.S. facilities. On money, expect flat rate at every dose — published upfront.
Behind the prescription sits 24/7 access to U.S.-based doctors, not just messaging. Available medication: compounded semaglutide.
TMates pros
- 24/7 access to U.S.-based doctors, not just messaging support
- Flat $199/month at every dose, no step-up fees as dosage escalates
- Medications formulated in U.S.-based facilities
- Licensed coverage in all 50 states
TMates cons
- $199/month is higher than the cheapest compounded options
- Compounded semaglutide only, limited public detail on tirzepatide availability
- No branded Ozempic, Wegovy, or Zepbound
Set beside Ro.co, the thing to weigh: semaglutide only, and $199 is well above the cheapest compounded options.
Who each program is actually built for
Choose Ro.co if:
- you want to start on their timeline: online consultation
- delivery works the way you want it to: home delivery
- the monthly rate is the constraint — $39/mo against $199/mo
- you want an FDA-approved finished medication rather than a compounded preparation
Choose TMates if:
- you want the price you sign up at to survive titration
- you are in a state where GLP-1 telehealth coverage is patchy
- you want the full price in front of you before completing an intake
- you would get real value from one flat $199 that survives every titration step, with doctors rather than a message queue behind it
The compromises on both sides
On price. The monthly gap is 5.1x in Ro.co's favor. Whether that is a saving or a false economy turns on one thing: an FDA-approved finished medication costs multiples of a compounded vial.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. Established full-service platform with clinician oversight at Ro.co; 24/7 access to U.S.-based doctors, not just messaging at TMates. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. Ro.co covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables; TMates covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
What the evidence actually says
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Ro.co vs TMates: common questions
Which is cheaper to start, Ro.co or TMates?
Ro.co, at $39 against $199. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Does the price go up as my dose increases?
At TMates, no — one flat $199 that survives every titration step, with doctors rather than a message queue behind it. At Ro.co, the published structure is promotional first month, then standard rate. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
Are Ro.co and TMates legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Ro.co operates on promotional first month, then standard rate with pricing partly published, TMates on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Can I switch from Ro.co to TMates later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
TMates's case is one flat $199 that survives every titration step, with doctors rather than a message queue behind it; its cost: semaglutide only, and $199 is well above the cheapest compounded options.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Directmeds vs Ro.coBrand-name vs compounded
- Enhance MD vs Ro.coBrand-name vs compounded
- Mochi Health vs TMatesBudget vs premium
- Elevate Health vs TMatesTirzepatide access
- Refills vs Ro.coBrand-name vs compounded
- Embody vs Ro.coBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Ro.co or TMates, and does not sell treatment. Read our ranking methodology.